Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report

Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD - Mayo Clinic

Ulcerative colitis - The Lancet

PDF) Review Article: Acute Severe Ulcerative Colitis, An Update on Optimal Medical Management

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis

Antidrug Antibodies to Infliximab and Adalimumab in IBD Management

Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience, BMC Gastroenterology

Ulcerative Colitis—Diagnostic and Therapeutic Algorithms (17.08.2020)

Pharmaceutics, Free Full-Text

Infliximab

Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar

JCM, Free Full-Text

PDF) Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.

Ulcerative colitis - The Lancet